The platform uses disposable microfluidic chips that perform end-to-end chemical and radiochemical reactions. Our automated synthesis technology platform addresses critical limitations in conventional diagnostic and therapeutic workflows by standardizing and streamlining radioimmunoconjugate and radiopharmaceutical manufacturing. The Radiosyn platform offers reproducible, high-quality radiopharmaceutical production across research and clinical settings, requiring minimal specialized radiochemistry expertise. Our mission is to accelerate scientific discovery and clinical use of radiopharmaceuticals by making their production more accessible, standardized, and scalable.